A phase II study of non-platinum based chemotherapy with paclitaxel and vinorelbine in non-small cell lung cancer

Lung Cancer

Volumn 38, Issue 2, 2002, Pages 199-203

  Ginopoulos, Panagiotis ^a   Kontomanolis, Emanuel ^a   Kardamakis, Dimitrios ^b   Sougleri, Maria ^a   Rathosis, Spiros ^a   Karana, Afroditi ^b   Christias, Helias ^a   Mandellos, George ^c  

^a UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Non small cell lung cancer; Paclitaxel; Phase II trials; Response rate; Toxicity; Vinorelbine

Indexed keywords

NAVELBINE; PACLITAXEL; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TOXICITY; FEMALE; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL TIME; CHEMICALLY INDUCED DISORDER; DISEASE FREE SURVIVAL; INTRAVENOUS DRUG ADMINISTRATION; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; ERYTHROPOIETIN; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFUSIONS, INTRAVENOUS; LEUKOPENIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; TREATMENT OUTCOME; VINBLASTINE;

EID: 0036837905     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00179-4     Document Type: Article

References (21)

1. Advanced non-small cell lung cancer chemotherapy: a randomized trial of two active regimens (MVP and PE)
2. Non-small cell lung cancer
3. Phase II study of Taxol in patients with untreated non-small cell lung cancer
4. Phase II study of Taxol, membrane and piroxantrone in stage IV non-small-cell lung cancer: the Eastern Cooperative Oncology Group results
5. Chemotherapy of advanced inoperable non-small cell cancer lung cancer with paclitaxel: a phase II trial
6. A phase II study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer
7. A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer
8. Modified weekly regimen with vinorelbine as a single agent in unresectable non-small cell lung cancer
9. Mechanism of action of Taxol
10. Interaction of vinblastine analogues with tubulin
11. Pilot study of vinorelbine (Navelbine) and paclitaxel in patients with refractory non-small cell lung cancer
12. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
13. Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology Group
14. Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial
15. Phase I study of Paclitaxel (Taxol) plus vinorelbine (Navelbine) in patients with untreated stage IIIb and IV non-small cell lung cancer
16. A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC)
17. A phase I-II study of paclitaxel, ifosfamide and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small cell lung cancer
18. Vinorelbine, paclitaxel and carboplatin (VPC) for adenocarcinoma of the lung
19. Use of dexamethasone in the management of phlebitis caused by intravenous administration of vinorelbine (navelbine)
20. Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitro